Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PFN2 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
mRNA | MMP17 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |
mRNA | PLEK2 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-06 |
mRNA | OR2B11 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | PRAM1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | PHLPP2 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | DPP7 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | ADAP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
mRNA | ITGA6 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-06 |
mRNA | EPHA1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |